ALID
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
1.28M
APNHY
Price
$5.88
Change
-$0.06 (-1.01%)
Updated
Aug 25 closing price
Capitalization
2.65B
Interact to see
Advertisement

ALID vs APNHY

Header iconALID vs APNHY Comparison
Open Charts ALID vs APNHYBanner chart's image
Allied
Price$0.01
Change-$0.00 (-0.00%)
Volume$300
Capitalization1.28M
Aspen Pharmacare Holdings
Price$5.88
Change-$0.06 (-1.01%)
Volume$875
Capitalization2.65B
ALID vs APNHY Comparison Chart in %
Loading...
ALID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALID vs. APNHY commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALID is a Buy and APNHY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (ALID: $0.01 vs. APNHY: $5.88)
Brand notoriety: ALID and APNHY are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALID: 67% vs. APNHY: 23%
Market capitalization -- ALID: $1.28M vs. APNHY: $2.65B
ALID [@Pharmaceuticals: Generic] is valued at $1.28M. APNHY’s [@Pharmaceuticals: Generic] market capitalization is $2.65B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.78B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALID’s FA Score shows that 0 FA rating(s) are green whileAPNHY’s FA Score has 1 green FA rating(s).

  • ALID’s FA Score: 0 green, 5 red.
  • APNHY’s FA Score: 1 green, 4 red.
According to our system of comparison, APNHY is a better buy in the long-term than ALID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALID’s TA Score shows that 4 TA indicator(s) are bullish while APNHY’s TA Score has 4 bullish TA indicator(s).

  • ALID’s TA Score: 4 bullish, 0 bearish.
  • APNHY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALID is a better buy in the short-term than APNHY.

Price Growth

ALID (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while APNHY (@Pharmaceuticals: Generic) price change was -5.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.59%. For the same industry, the average monthly price growth was +10.75%, and the average quarterly price growth was +74.71%.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.59% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHY($2.65B) has a higher market cap than ALID($1.28M). APNHY YTD gains are higher at: -28.814 vs. ALID (-67.353). APNHY has higher annual earnings (EBITDA): 8.02B vs. ALID (-2.93M). APNHY has more cash in the bank: 6.8B vs. ALID (195K). ALID has less debt than APNHY: ALID (6.71M) vs APNHY (35.5B). APNHY has higher revenues than ALID: APNHY (45.5B) vs ALID (105K).
ALIDAPNHYALID / APNHY
Capitalization1.28M2.65B0%
EBITDA-2.93M8.02B-0%
Gain YTD-67.353-28.814234%
P/E RatioN/A10.18-
Revenue105K45.5B0%
Total Cash195K6.8B0%
Total Debt6.71M35.5B0%
FUNDAMENTALS RATINGS
ALID vs APNHY: Fundamental Ratings
ALID
APNHY
OUTLOOK RATING
1..100
3577
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8787
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHY's Valuation (9) in the null industry is significantly better than the same rating for ALID (87). This means that APNHY’s stock grew significantly faster than ALID’s over the last 12 months.

APNHY's Profit vs Risk Rating (100) in the null industry is in the same range as ALID (100). This means that APNHY’s stock grew similarly to ALID’s over the last 12 months.

APNHY's SMR Rating (99) in the null industry is in the same range as ALID (100). This means that APNHY’s stock grew similarly to ALID’s over the last 12 months.

APNHY's Price Growth Rating (87) in the null industry is in the same range as ALID (87). This means that APNHY’s stock grew similarly to ALID’s over the last 12 months.

APNHY's P/E Growth Rating (94) in the null industry is in the same range as ALID (100). This means that APNHY’s stock grew similarly to ALID’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALIDAPNHY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
66%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ALID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IMRFX14.94N/A
N/A
Columbia Global Opportunities A
GLNMX25.56N/A
N/A
MFS Global New Discovery R4
AVUSX20.27N/A
N/A
Avantis® U.S. Equity Institutional
TAGHX33.43N/A
N/A
Transamerica US Growth R6
JDMRX129.86-1.14
-0.87%
Janus Henderson Enterprise R

ALID and

Correlation & Price change

A.I.dvisor tells us that ALID and ABSCF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALID and ABSCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALID
1D Price
Change %
ALID100%
N/A
ABSCF - ALID
16%
Poorly correlated
N/A
ARSUF - ALID
8%
Poorly correlated
N/A
APNHY - ALID
6%
Poorly correlated
-1.01%
YCBD - ALID
4%
Poorly correlated
+5.21%
ORGO - ALID
2%
Poorly correlated
-4.50%
More

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TRUFF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TRUFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
-1.01%
TRUFF - APNHY
21%
Poorly correlated
-7.24%
PRFX - APNHY
20%
Poorly correlated
+2.96%
ESALF - APNHY
20%
Poorly correlated
+0.38%
SDZNY - APNHY
20%
Poorly correlated
-0.18%
BIOVF - APNHY
19%
Poorly correlated
N/A
More